Method for determining the risk of developing liver cancer, a kit for determining the risk of developing liver cancer, and a pharmaceutical composition

摘要

PROBLEM TO BE SOLVED: To provide a method for determining a risk of developing liver cancer and a kit for determining the risk of developing liver cancer, which can determine the risk of developing liver cancer regardless of the hepatitis virus. A method for determining a risk of developing liver cancer, which comprises a step of measuring the content of a gelE gene or a gene product thereof in a target fecal sample. A kit for determining the risk of developing liver cancer, which comprises a reagent for measuring the content of the gelE gene in the target fecal sample. Further, a pharmaceutical composition for reducing the risk of developing liver cancer, which is administered to a subject determined to have a high risk of developing liver cancer by the method for determining the risk of developing liver cancer, and is a large intestine of the subject. A pharmaceutical composition comprising an agent that reduces the number of bacteria having the gelE gene within. [Selection diagram] None